Streamlining Drug Approvals: Addressing Policy Challenges in Genitourinary Oncology

859
Total downloads
3,700
Total views and downloads

Participate in this topic

Articles

REVIEW

Published on 25 Jun 2025

Changing landscape of first-line treatment for locally advanced or metastatic urothelial carcinoma: the progression from platinum-based chemotherapy to platinum-free therapy

Zengguang Liu
Chen Chen
Jiaxin Yin
Xiaofeng Cong
Ziling Liu

doi 10.3389/fimmu.2025.1604395

215 views

ORIGINAL RESEARCH

Published on 09 Sep 2024

Cost-effectiveness of first-line enfortumab vedotin in addition to pembrolizumab for metastatic urothelial carcinoma in the United States

Andong Li
Meiyu Wu
Ouyang Xie
Heng Xiang
Kehui Meng
Chongqing Tan
Long Wang
Xiaomin Wan

doi 10.3389/fimmu.2024.1464092

2,646 views
5 citations

Share on

Frontiers in Immunology

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Health Services
- Cost and Resource Allocation
- 2.7 impact factor
- 2.5 citescore
Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.3 impact factor
- 6.9 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

3,700Topic views
2,307Article views
859Article downloads